Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole

Journal of Clinical Microbiology

Volumn 34, Issue 5, 1996, Pages 1280-1282

  Sanati, Homayoon ^a   Messer, Shawn A ^b   Pfaller, Michael ^b   Witt, Mallory ^c   Larsen, Robert ^d,e   Espinel Ingroff, Ana ^f   Ghannoum, Mahmoud ^a,g,h  

^a Division of Infectious Diseases   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h St John's Cardiovascular Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD CULTURE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID EXAMINATION; CLINICAL TRIAL; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; FUNGAL MENINGITIS; FUNGUS CULTURE; HUMAN; LABORATORY TEST; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

EID: 0029979329     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.5.1280-1282.1996     Document Type: Article

References (17)

1. Chuck, S. L., and M. A. Sande. 1989. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N. Engl. J. Med. 321:794-799.
2. Currie, B. P., M. Ghannoum, L. Bessen, and A. Casadevall. 1995. Decreased fluconazole susceptibility of a relapse Cryptococcus neoformans isolate after fluconazole treatment. Infect. Dis. Clin. Pract. 4:318-319.
3. Eng, R. H. K., E. Bishburg, and S. M. Smith. 1986. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am. J. Med. 81:19-23.
4. Espinel-Ingroff, A., C. W. Kish, Jr., T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Geraeden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol 30:3138-3145.
5. Ghannoum, M. A., A. S. Ibrahim, Y. Fu, M. C. Shafiq, J. E. Edwards, Jr., and R. S. Criddle. 1992. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J. Clin. Microbiol. 30:2881-2886.
6. Kwon-Chung, K. J., and J. E. Bennett. 1992. Medical mycology, p. 421-426. Lea & Febiger, Malvern, Pa.
7. Larsen, R. A., S. A. Bozzette, B. E. Jones, D. Haghighat, and M. A. Leal. 1994. Fluconazole combined with flucytosine for cryptococcal meningitis in persons with AIDS. Clin. Infect. Dis. 19:741-745.
8. Milefchik, E., M. Leal, R. Haubrich, R. See, S. Bozzette, and R. Larsen. 1993. High dose fluconazole with and without flucytosine for AIDS associated cryptococcal meningitis, abstr. WS-B5-12. In Programs and abstracts: IX International Conference on AIDS/IVth STD World Congress (Berlin). Wellcome Foundation, London.
9. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeast; proposed standard, M27-P. National Committee for Clinical Laboratory Standards. Villanova, Pa.
10. Palo de Fernandez, E., M. M. Patino, J. R. Graybill, and M. H. Tarbit. 1986 Treatment of cryptococcal meningitis in mice with fluconazole. J. Antimicrob. Chemother. 18:261-270.
11. Pfaller, M. A., B. Buschelman, M. J. Bale, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, and M. G. Rinaldi. 1994. Multicenter comparison of a colorimetric microdilution method for in vitro susceptibility testing of yeast isolates. Diagn. Microbiol. Infect. Dis. 19:9-13.
12. Pfaller, M. A., C. Grant, V. Morthland, and J. Rhine-Chalberg. 1994. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J. Clin. Microbiol. 32:506-509.
13. Pfaller, M. A., Q. Vu, M. Lancaster, A. Espinel-Ingroff, A. Fothergill, C. Grant, M. R. McGinnis, L. Pasarell, M. G. Rinaldi, and L. Steele-Moore, 1994. Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1625-1628.
14. Saag, M. S., W. G. Powderly, G. A. Cloud, P. Robinson, M. H. Grieco, P. K. Sharkey, S. E. Thompson, A. M. Sugar, C. U. Tuazon, J. F. Fisher, N. Hyslop, J. M. Jacobson, R. Hafner, W. E. Dismukes, the NIAID Mycoses Study Group, and the AIDS Clinical Trials Group. 1992. Comparison of amphotericin B with fluconazole in treatment of acute AIDS-associated cryptococcal meningitis. N. Engl. J. Med. 326:83-89
15. Selik, R. M., E. T. Starcher, and J. W. Curran. 1987. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends AIDS 1:175-182.
16. Stern, J. J., B. J. Hartman, P. Sharkey, V. Rowland, K. E. Squires, H. W. Murray, and J. R. Graybill. 1988. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am. J. Med. 85:477-480.
17. Witt, M. D., R. J. Lewis, R. A. Larsen, E. N. Milefchik, M. A. E. Leal, R. A. Haubrich, J. A. Richie, J. E. Edwards, Jr., and M. A. Ghannoum. 1996. Identification of patients with acute AIDS-associated cryptococcal meningitis suitable for fluconazole therapy: the role of antifungal susceptibility testing. Clin. Infect. Dis. 22:322-328.